Delivery Order SPE2DB20D3303-SPE2DB24FA1XH

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,768.07 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, with an ultimate completion date of August 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of Cyclosporine 0.05% eye emulsion. The fixed-price delivery order is valued at $4,622.12 and has an ultimate completion date of August 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of medical products and medications to federal agencies and healthcare programs. The contract is not set aside for any...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,068.74 firm fixed price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, with a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,108.58 firm fixed price delivery order is for the procurement of Cyclosporine 0.05% eye emulsion, with a completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,806.05 Firm Fixed Price Delivery Order is for the supply of 30 units of Cyclosporine 0.05% Eye Emulsion, with a completion date of July 25, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,828.28 firm fixed price Delivery Order is for the supply of Cyclosporine 0.05% Eye Emulsion, with a completion date of May 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999.00 from DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Cyclosporine 0.05% eye emulsion. The $1,611.54 firm fixed-price delivery order has a completion date of January 18, 2023 and was awarded on January 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a Delivery Order valued at $7,949.34 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a period of performance through June 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,034.20 firm fixed-price delivery order is for the supply of CYCLOSPORINE 0.05% EYE EMULS 60S, a specialty pharmaceutical product. The award has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,629.21 firm fixed-price delivery order is for the procurement of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has a performance period that runs through December 29, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA1XH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The $10,634.42 firm fixed price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a critical pharmaceutical product. The contract has an ultimate completion date of August 9, 2024.

Amerisourcebergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. These IDCs, valued up to $999,999,999 and $750,000, enable government agencies to efficiently procure essential pharmaceutical and medical products to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. This specific award is not designated as a set-aside contract.

Generated 11/7/24, 9:22 AM